Candriam S.C.A. Invitae Corp Transaction History

Candriam S.C.A.

  • $16.3 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$1.2 - $2.73 $68,784 - $156,483
-57,320 Reduced 15.77%
306,051 $413,000
Q4 2022

Feb 13, 2023
BUY
$1.71 - $3.61 $24,411 - $51,536
14,276 Added 4.09%
363,371 $675,000
Q3 2022

Nov 10, 2022
BUY
$1.9 - $8.63 $663,280 - $3.01 Million
349,095 New
349,095 $859,000

Others Institutions Holding NVTA

# of Institutions
38
Shares Held
2.12M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email